Tim Andrews became the first patient to transition from a pig kidney transplant to a human kidney. He lived for 271 days with a genetically modified pig kidney, during which he did not need dialysis.
The initial transplant was performed as part of a clinical study by biotechnology company eGenesis. The pig kidney was genetically modified to reduce the risk of rejection by the human body.
After nearly nine months of functioning correctly, Andrews finally received a human donor kidney. The procedure was considered a success and marks a significant advancement in transplant research.
This case represents an important step in the search for solutions to the organ shortage for transplantation. Researchers hope that, in the future, genetically modified animal kidneys could be used temporarily or permanently in human patients.
